Nevertheless, a screen of T-ALL patients revealed a chromosomal translocation that juxtaposes NKX2-4 to the TCRA gene, supporting its oncogenic activity in hematopoietic malignancies [46]. This evidence concerns the gene NKX2-4 and acute lymphoblastic leukemia.